News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Gilead Sciences, Inc.
NEWS
JOBS
IN THE PRESS
NEWS
Biotech Bay
Why Gilead Could Be a Gold Mine for Value Investors
April 17, 2017
·
1 min read
Deals
What Happens if Gilead Went Bigger Than Incyte and Made a Play for This Pharma Giant
April 10, 2017
·
2 min read
FDA
Gilead Release: FDA Approves New Indications For Harvoni And Sovaldi In Pediatric Patients 12 Years And Older With Chronic Hepatitis C Infection
April 7, 2017
·
10 min read
Job Trends
Gilead Quietly Starts Recruiting Employees for China Expansion
April 7, 2017
·
3 min read
Business
Ex-Gilead Director Founded and Will Helm Bay Area Cancer Startup Apostle
April 3, 2017
·
3 min read
Biotech Bay
Has Gilead Lost Its Way?
March 31, 2017
·
1 min read
Drug Development
How This Drug Candidate Could be a Winner in Gilead’s Pipeline
March 21, 2017
·
3 min read
BioMidwest
4 Small-Cap Biotechs to Consider if Gilead Isn’t Doing it For You
March 21, 2017
·
2 min read
Biotech Bay
3 Numbers That Make Gilead Look Cheaper Than It Really Is
March 17, 2017
·
1 min read
JOBS
Currently, there are no jobs for this company on BioSpace
Browse all jobs
here
Oops!
There was an issue retrieving the jobs list. Please reload the page to view more jobs.
Title
Location
Company Name
Desc
View details
IN THE PRESS
Biotech Bay
Gilead Announces Third Quarter 2017 Dividend
July 27, 2017
·
1 min read
Drug Development
Gilead Boosted By New Late-Stage HIV Data
July 24, 2017
·
6 min read
Business
Gilead To Release Second Quarter 2017 Financial Results On Wednesday, July 26, 2017
July 13, 2017
·
1 min read
Biotech Bay
EMA Validates Gilead’s Marketing Application For Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide For Treatment Of HIV
July 13, 2017
·
4 min read
Business
Spring Bank Pharmaceuticals, Inc. Announces Collaboration With Gilead For Hepatitis B (HBV) Phase II Study Exploring Combination Treatment Of SB 9200 And Vemlidy
July 10, 2017
·
4 min read
Biotech Bay
European CHMP Adopts Positive Opinion For Gilead’s Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir) For The Treatment Of All Chronic Hepatitis C Genotypes
June 23, 2017
·
4 min read
Policy
Gilead Submits New Drug Application To U.S. FDA For Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide For HIV Treatment
June 12, 2017
·
3 min read
Deals
GlaxoSmithKline Quietly Paid $130 Million for HIV Priority Voucher to Beat Gilead to the Finish Line
June 2, 2017
·
12 min read
Drug Development
Gilead’s Investigational Fixed-Dose Combination Of Bictegravir, Emtricitabine And Tenofovir Alafenamide For The Treatment Of HIV-1 Meets Primary Endpoint In Four Phase III Studies
May 30, 2017
·
5 min read
Drug Development
Gilead Release: Multiple Provinces And Territories Demonstrate Leadership In The Treatment Of HIV/AIDS By Providing Access To GENVOYA
May 8, 2017
·
4 min read
